[O-05] Cerebrovascular disease (medical treatment)

[O-05-2] Association between poststroke disability and apixaban plasma concentration, Anti- Xa activity

^○Masaya Kumamoto¹, Kazunori Toyoda¹, Shinichi Wada¹, Naoki Tagawa¹, Takayuki Matuki¹, Takuya Okata¹, Akira Okamoto², Toshiyuki Miyata¹, Masafumi Ihara³, Masatoshi Koga¹ (1.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, 2.Department of Clinical Laboratory, National Cerebral and Cardiovascular Center, 3.Department of Neurology, National Cerebral and Cardiovascular Center)